Teva Pharmaceutical Industries Ltd. (TEVA)
34.37
-0.10
(-0.29%)
USD |
NYSE |
Feb 10, 16:00
34.71
+0.34
(+0.99%)
Pre-Market: 08:32
Teva Pharmaceutical Industries Shareholders Equity (Quarterly) : 7.910B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | -- |
| Compugen Ltd. | 43.83M |
| Royalty Pharma Plc | 6.414B |
| Pluri, Inc. | -11.36M |
| BioLineRx Ltd. | 19.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.75B |
| Total Liabilities (Quarterly) | 32.83B |
| Debt to Equity Ratio | 2.173 |
| Current Ratio | 1.036 |
| Net Debt Paydown Yield | 1.16% |